Patents

Last Modified: May 3, 2022

Cleerly continues to revolutionize heart attack and cardiovascular disease prevention and treatment everyday by inventing world-class technology.  Cleerly invests significant time and resources in research and development towards this goal.  To protect Cleerly’s research and development efforts, Cleerly has vigorously developed a robust intellectual property portfolio - all part of a strategy for protecting the innovations that make Cleerly an industry leader in cardiovascular disease prevention and treatment.

Cleerly’s products and services may be covered by or for use under one or more of U.S. Patent Nos. 10,813,612, 11,094,060, 11,094,061, 11,113,811, 11,120,549, 11,120,550, 11,132,796, 11,210,786, 11,232,564, 11,238,587, 11,244,451, 11,276,170, 11,288,799, 11,302,001, 11,302,002, 11,308,617, 11,315,247, 11,317,883, and 11,321,840, as well as other patents that are pending.  

For additional information, please contact legal@cleerlyhealth.com.